The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia

The objective was to compare the clinical efficacy of cefoperazone-sulbactam with piperacillin-tazobactam in the treatment of severe community-acquired pneumonia (SCAP). The retrospective study was conducted from March 1, 2018 to May 30, 2019. Clinical outcomes were compared for patients who receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chih-Cheng, Chen, Wei-Chih, Kuo, Li-Kuo, Wang, Yao-Tung, Fu, Pin-Kuei, Ku, Shih-Chi, Fang, Wen-Feng, Chen, Chin-Ming, Tu, Chih-Yen, Cheng, Wen-Chien, Chen, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344575/
https://www.ncbi.nlm.nih.gov/pubmed/37443505
http://dx.doi.org/10.1097/MD.0000000000034284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344575/
https://www.ncbi.nlm.nih.gov/pubmed/37443505
http://dx.doi.org/10.1097/MD.0000000000034284

Ejemplares similares